Latest venBio Partners LLC Stock Portfolio
$280Million– No. of Holdings #6
venBio Partners LLC Performance:
2026 Q1: 27.74%YTD: 27.74%2025: 26.25%
Performance for 2026 Q1 is 27.74%, and YTD is 27.74%, and 2025 is 26.25%.
About venBio Partners LLC and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, venBio Partners LLC reported an equity portfolio of $280.6 Millions as of 31 Mar, 2026.
The top stock holdings of venBio Partners LLC are PHVS, , ALXO. The fund has invested 46.7% of it's portfolio in PHARVARIS N V and 35.6% of portfolio in ALUMIS INC.
They significantly reduced their stock positions in ARTIVA BIOTHERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ALX ONCOLOGY HLDGS INC (ALXO).
The top stock holdings of venBio Partners LLC are PHVS, , ALXO. The fund has invested 46.7% of it's portfolio in PHARVARIS N V and 35.6% of portfolio in ALUMIS INC.
They significantly reduced their stock positions in ARTIVA BIOTHERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ALX ONCOLOGY HLDGS INC (ALXO).
venBio Partners LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
venBio Partners LLC Annual Return Estimates Vs S&P 500
Our best estimate is that venBio Partners LLC made a return of 27.74% in the last quarter. In trailing 12 months, it's portfolio return was 116.18%.
- Performance
- S&P 500
New Buys
Additions
| Ticker | % Inc. |
|---|---|
| alx oncology hldgs inc | 32.83 |
Additions to existing portfolio by venBio Partners LLC
Reductions
| Ticker | % Reduced |
|---|---|
| artiva biotherapeutics inc | -18.07 |
| alumis inc | -1.98 |
venBio Partners LLC reduced stake in above stock
Sold off
Sector Distribution
venBio Partners LLC has about 83.5% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 83.5 |
| Healthcare | 16.5 |
Market Cap. Distribution
venBio Partners LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MICRO-CAP
- MID-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 83.5 |
| MICRO-CAP | 9.2 |
| MID-CAP | 4.9 |
| SMALL-CAP | 2.4 |
Stocks belong to which Index?
About 16.5% of the stocks held by venBio Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 83.5 |
| RUSSELL 2000 | 16.5 |
venBio Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of venBio Partners LLC
venBio Partners LLC has 6 stocks in it's portfolio. HRMY proved to be the most loss making stock for the portfolio. was the most profitable stock for venBio Partners LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALXO | alx oncology hldgs inc | 9.21 | 12,884,600 | 25,833,700 | added | 32.83 | ||
| HRMY | harmony biosciences hldgs in | 4.88 | 489,194 | 13,702,300 | unchanged | 0.00 | ||
| LYEL | lyell immunopharma inc | 2.42 | 337,697 | 6,774,200 | unchanged | 0.00 | ||
| PHVS | pharvaris n v | 46.72 | 4,639,300 | 131,060,000 | unchanged | 0.00 | ||
| alumis inc | 35.56 | 4,528,410 | 99,760,800 | reduced | -1.98 | |||
| artiva biotherapeutics inc | 1.22 | 531,337 | 3,421,810 | reduced | -18.07 | |||